ARMATA PHARMACEUTICALS INC (ARMP) Stock Income Statement
NYSEARCA:ARMP - NYSE Arca - US04216R1023 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.70M | 5.17M | 4.53M | 5.51M | 4.47M | |||
| Operating Expenses | 45.10M | 47.61M | 45.42M | 42.45M | 28.30M | |||
| Research and Development | 31.84M | 34.43M | 33.77M | 35.02M | 20.02M | |||
| Selling, General, and Administrative Expenses | 13.26M | 13.18M | 11.65M | 7.44M | 8.28M | |||
| Operating Income | -40.40M | -42.44M | -40.89M | -36.95M | -23.83M | |||
| Interest Income/Expense | 37.81M | 21.35M | -24.29M | 30.00K | -60.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | 0.00 | |||
| Non Recurring Items | N/A | 2.17M | -3.86M | 0.00 | 730.00K | |||
| Income Before Taxes | -426.00K | -18.92M | -69.05M | -36.92M | -23.16M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -426.00K | -18.92M | -69.05M | -36.92M | -23.16M | |||
| EBITDA | -39.02M | -41.11M | -39.92M | -36.06M | -22.66M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.11 | -0.52 | -1.91 | -1.08 | -0.96 | |||
| Non GAAP EPS | -0.03 | -0.52 | -1.80 | -1.09 | -0.97 | |||
| Statistics | ||||||||
| Profit Margin | -9.07% | -365.60% | -1524.51% | -670.05% | -518.12% | |||
| Operating Profit Margin | -859.76% | -820.18% | -902.85% | -670.60% | -533.11% | |||
All data in USD